This repository accompanies the research paper "Implications of Language Choice for Algorithmic Efficiency in Low-Power Computing." The study investigates how the choice of programming ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.

Abstract: The demand for large integer polynomial multiplications has become increasingly significant in modern cryptographic algorithms. The practical implementation of such multipliers presents a ...

Abstract: Most approximation computing research focuses on arithmetic operations like binary multiplication, division, and addition. Squaring, another fundamental arithmetic operation, is commonly ...

@misc{yan2025instantgaussianstreamfast, title={Instant Gaussian Stream: Fast and Generalizable Streaming of Dynamic Scene Reconstruction via Gaussian Splatting ...